Dataset Information

Direct binding to integrins and loss of disulfide linkage in interleukin-1? (IL-1?) are involved in the agonistic action of IL-1?.

ABSTRACT: There is a strong link between integrins and interleukin-1? (IL-1?), but the specifics of the role of integrins in IL-1? signaling are unclear. We describe that IL-1? specifically bound to integrins ?v?3 and ?5?1. The E128K mutation in the IL1R-binding site enhanced integrin binding. We studied whether direct integrin binding is involved in IL-1? signaling. We compared sequences of IL-1? and IL-1 receptor antagonist (IL1RN), which is an IL-1? homologue but has no agonistic activity. Several surface-exposed Lys residues are present in IL-1?, but not in IL1RN. A disulfide linkage is present in IL1RN, but is not in IL-1? because of natural C117F mutation. Substitution of the Lys residues to Glu markedly reduced integrin binding of E128K IL-1?, suggesting that the Lys residues mediate integrin binding. The Lys mutations reduced, but did not completely abrogate, agonistic action of IL-1?. We studied whether the disulfide linkage plays a role in agonistic action of IL-1?. Reintroduction of the disulfide linkage by the F117C mutation did not affect agonistic activity of WT IL-1?, but effectively reduced the remaining agonistic activity of the Lys mutants. Also, deletion of the disulfide linkage in IL1RN by the C116F mutation did not make it agonistic. We propose that the direct binding to IL-1? to integrins is primarily important for agonistic IL-1? signaling, and that the disulfide linkage indirectly affects signaling by blocking conformational changes induced by weak integrin binding to the Lys mutants. The integrin-IL-1? interaction is a potential target for drug discovery.

SUBMITTER: Takada YK

PROVIDER: S-EPMC5723996 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Direct binding to integrins and loss of disulfide linkage in interleukin-1β (IL-1β) are involved in the agonistic action of IL-1β.

Takada Yoko K YK Yu Jessica J Fujita Masaaki M Saegusa Jun J Wu Chun-Yi CY Takada Yoshikazu Y

The Journal of biological chemistry 20171013 49

There is a strong link between integrins and interleukin-1β (IL-1β), but the specifics of the role of integrins in IL-1β signaling are unclear. We describe that IL-1β specifically bound to integrins αvβ3 and α5β1. The E128K mutation in the IL1R-binding site enhanced integrin binding. We studied whether direct integrin binding is involved in IL-1β signaling. We compared sequences of IL-1β and IL-1 receptor antagonist (IL1RN), which is an IL-1β homologue but has no agonistic activity. Several surf ...[more]

PMID: 29030430

Similar Datasets

Project description:Duchenne muscular dystrophy (DMD) is a severe X-linked recessive muscle disorder caused by mutations in the dystrophin gene. Nonetheless, secondary processes involving perturbation of muscle regeneration probably exacerbate disease progression, resulting in the fatal loss of muscle in DMD patients. A dysfunction of undifferentiated myogenic cells is the most likely cause for the reduction of regenerative capacity of muscle. To clarify molecular mechanisms in perturbation of the regenerative capacity of DMD muscle, we have established several NCAM (CD56)-positive immortalized human dystrophic and non-dystrophic myogenic cell lines from DMD and healthy muscles. A pro-inflammatory cytokine, IL-1?, promoted cell cycle progression of non-dystrophic myogenic cells but not DMD myogenic cells. In contrast, IL-1? upregulated the Notch ligand Jagged1 gene in DMD myogenic cells but not in non-dystrophic myogenic cells. Knockdown of Jagged1 in DMD myogenic cells restored the IL-1?-promoted cell cycle progression. Conversely, enforced expression of Jagged1-blocked IL-1? promoted proliferation of non-dystrophic myogenic cells. In addition, IL-1? prevented myogenic differentiation of DMD myogenic cells depending on Jagged1 but not of non-dystrophic myogenic cells. These results demonstrate that Jagged1 induced by IL-1? in DMD myogenic cells modified the action of IL-1? and reduced the ability to proliferate and differentiate. IL-1? induced Jagged1 gene expression may be a feedback response to excess stimulation with this cytokine because high IL-1? (200-1000 pg/ml) induced Jagged1 gene expression even in non-dystrophic myogenic cells. DMD myogenic cells are likely to acquire the susceptibility of the Jagged1 gene to IL-1? under the microcircumstances in DMD muscles. The present results suggest that Jagged1 induced by IL-1? plays a crucial role in the loss of muscle regeneration capacity of DMD muscles. The IL-1?/Jagged1 pathway may be a new therapeutic target to ameliorate exacerbation of muscular dystrophy in a dystrophin-independent manner.

Project description:BACKGROUND:Systemic inflammation has been linked to synapse loss and cognitive decline in human patients and animal models. A role for microglial release of pro-inflammatory cytokines has been proposed based on in vivo and primary culture studies. However, mechanisms are hard to study in vivo as specific microglial ablation is challenging and the extracellular fluid cannot be sampled without invasive methods. Primary cultures have different limitations as the intricate multicellular architecture in the brain is not fully reproduced. It is essential to confirm proposed brain-specific mechanisms of inflammatory synapse loss directly in brain tissue. Organotypic hippocampal slice cultures (OHSCs) retain much of the in vivo neuronal architecture, synaptic connections and diversity of cell types whilst providing convenient access to manipulate and sample the culture medium and observe cellular reactions. METHODS:OHSCs were generated from P6-P9 C57BL/6 mice. Inflammation was induced via addition of lipopolysaccharide (LPS), and cultures were analysed for changes in synaptic proteins, gene expression and protein secretion. Microglia were selectively depleted using clodronate, and the effect of IL1? was assessed using a specific neutralising monoclonal antibody. RESULTS:LPS treatment induced loss of the presynaptic protein synaptophysin without altering PSD95 or A? protein levels. Depletion of microglia prior to LPS application prevented the loss of synaptophysin, whilst microglia depletion after the inflammatory insult was partially effective, although less so than pre-emptive treatment, indicating a time-critical window in which microglia can induce synaptic damage. IL1? protein and mRNA were increased after LPS addition, with these effects also prevented by microglia depletion. Direct application of IL1? to OHSCs resulted in synaptophysin loss whilst pre-treatment with IL1? neutralising antibody prior to LPS addition prevented a significant loss of synaptophysin but may also impact basal synaptic levels. CONCLUSIONS:The loss of synaptophysin in this system confirms LPS can act directly within brain tissue to disrupt synapses, and we show that microglia are the relevant cellular target when all major CNS cell types are present. By overcoming limitations of primary culture and in vivo work, our study strengthens the evidence for a key role of microglia-derived IL1? in synaptic dysfunction after inflammatory insult.

Dataset Information

Direct binding to integrins and loss of disulfide linkage in interleukin-1? (IL-1?) are involved in the agonistic action of IL-1?.

Publications

Direct binding to integrins and loss of disulfide linkage in interleukin-1β (IL-1β) are involved in the agonistic action of IL-1β.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets